The number of Australians living with diabetes could be up to 35% higher than previously estimated, according to new research from the University of

EssilorLuxottica has released new six-year clinical data, reinforcing the long-term efficacy of Essilor Stellest lenses in managing myopia progression and axial elongation in children

Australia’s healthcare and pharmaceuticals manufacturing sector is expected to face a disproportionate impact from global tariffs, according to risk management company Fair Supply

ZEISS Australia New Zealand has now become the sole supplier of DORC (Dutch Ophthalmic Research Center) products in Australia.